WILSTART, poudres and solvants for solution for injection bottle, 10 ml
Active ingredients: FACTEUR VIII DE COAGULATION HUMAIN, Antihemophilic factor, human recombinant
Commercialized according to BDPMDispensing in France: Prescription only
Solvent and powder for solution for injectionbottle, 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- WILSTART, poudres et solvants pour solution injectable
- Pharmaceutical form
- solvant(s) et poudre(s) pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de poudre de 1000 UI - 1 flacon(s) en verre de solvant de 10 ml - 1 flacon(s) en verre de poudre de 500 UI - 1 flacon(s) en verre de solvant de 5 ml avec deux dispositif(s) de transfert
- Marketing authorisation holder
- LFB-BIOMEDICAMENTS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69970324CIP75645167CIP133400956451678Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FACTEUR WILLEBRAND DE COAGULATION HUMAINpoudre du composant 1 | 100 UI · 1 mL de solution reconstituée | SA |
| FACTEUR VIII DE COAGULATION HUMAINpoudre du composant 2 | 100 UI · 1 mL de solution reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.